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Dangers in the AirWe Breathe
Although the air we breathe is necessary for
life, certain factors may make this same air
detrimental to our health. For instance, a
seemingly endless list ofcompounds can be
toxic at certain concentrations, and inhaling
such compounds may lead to damage in
different parts of the body. To investigate
the particular effects of inhaled toxicants,
the NIEHS developed the Respiratory
Toxicology Group. The group, which con-
sists of toxicologist Dan Morgan, biologist
Cassandra Shines, and engineer Michael
Moorman, has been conducting experi-
ments for about a decade at the NIEHS
inhalation facility. Morgan says the group
typically conducts studies ofchemicals that
have been nominated to the National
Toxicology Program for investigation into
their carcinogenic potential and other end
points. "We provide research support and
conduct special studies on these chemicals,"
he says. "We also do collaborative studies
with other NIEHS investigators, other [fed-
eral] agencies such as the Environmental
Protection Agency and the Department of
Energy, universities, and industry."
NosingAround
The group uses two methods to perform
inhalation experiments. In so-called nose-
only exposures, the investigators place a rat
or mouse in a plastic device that looks like a
soft drink bottle without a bottom, and a
prescribed mixture ofair is delivered to the
animal's nose through the neck ofthe "bot-
tle." In whole-body exposure studies, many
animals-each in its own cage-can be
exposed to toxicants simultaneously in a
1,000- to 2,000-liter chamber. In this tech-
nique, the investigators must make sure
that the air mixture is the same throughout
the chamber. Says Moorman, "When we
set it up, we sample from all the corners
and down the middle-18 different spots,
typically-and verify that [atmospheric
concentrations are] within 5%. When we
actually run the chamber, samples are taken
from one spot that's representative."
To get the proper mixture ofair to the
animals, the investigators use what
Moorman calls "a couple of pieces of
plumbing." If they need to vaporize a liq-
uid, one device sprays it into a glass pipe,
where it evaporates into the air being deliv-
ered to the animals. Ifa compound is high-
ly volatile or will be deployed at a very low
concentration, vapor is drawn from the
headspace ofa vial containing the exposure
compound. Metering pumps introduce the
vapor to the airstream. All ofthese processes
are monitored and controlled by a comput-
er. What makes these studies tricky,
Moorman says, is that they require docu-
menting what happens inside the cham-
bers-"guaranteeing that the atmospheric
concentration is what we plan for it to be
and accumulating the data to support that,
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which includes temperature, humidity, and
the time ofday thatwe do things."
The investigators use different devices
to measure the amounts of different gases
being inhaled by the test animals. With
mercury, for instance, they rely on a dedi-
cated analyzer. To measure the amounts of
most common gas vapors, they use a gas
chromatograph with a photo-ionization
detector. During an experiment, the investi-
gators might also gather physiological and
biochemical data through sampling of
blood or urine, measuring changes in body
temperature, or determining respiratory
rates of the test animals while they breathe
the exposure atmosphere.
OfMice and Men and Mercury
Currently, the Respiratory Toxicology
Group is exploring the health effects of
inhaling elemental mercury vapor. Says
Morgan, "The first mercury study we did
was in response to studies conducted by
NIEHS epidemiologist Andy Rowland that
showed that female dental hygienists, who
are exposed to mercury quite often in
preparing fillings, had more problems con-
ceiving than [women who were not
exposed]. So, in order to study the mecha-
nism of this effect, we tried to duplicate
those results in animals." Of the results
Morgan says, "We weren't able to repro-
duce any of those effects in our animal
model. [However], it may be that longer
exposures to lower concentrations may
result in reproductive toxicity." The
research paper on this work is
currently in press.
Still, the group continues
to worry about exposures to
> mercury vapor. Besides expo-
sures from fillings, mercury is
> also released as an emission
> from coal-fired power plants.
Currently, the group is explor-
ing how mercury inhaled by
pregnant women is transferred
to the fetus. In particular, they
want to determine how much
mercury makes its way into the
fetal brain and, once there, ifit
can create behavioral problems.
In studies, the group is expos-
ing pregnant rats to various
concentrations of mercury
vapor and then examining
mercury concentrations in vari-
ous tissues. Although the pro-
ject is ongoing, Morgan says,
"We have detected consider-
able amounts of mercury get-
ting through the placenta into
the fetus. This is a potential
problem." Nevertheless, he
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Breath tests. For whole-body exposure studies, test animals are placed in cages that are then sealed inside a large chamber, which is filled with
gases (1). Nose-only studies utilize a tree-like device (r) that delivers vapors directly to the animals' respiratory systems.
adds, the studies have not shown much evi-
dence of ensuing behavioral problems as a
result of such mercury exposure, but data
are still being analyzed.
Much of the concern about mercury
surrounds a troubling characteristic of the
element: once it is inhaled, it accumulates in
the body and stays there. Perhaps worse yet,
it often collects in the brain or other nervous
system tissue. The question is whether it's
possible then to eventually rid the body of
it. Some practitioners of alternative medi-
cine claim that various compounds, includ-
ing glutathione and vitamin C, can bind
mercury and eliminate it from the body. To
test these claims, the RespiratoryToxicology
Group has exposed rats to concentrations of
mercury vapor that lead to high concentra-
tions in the brain, and then treated them
with various combinations of glutathione
and vitamin C and with 2,3-dimercapto-
propane-1-sulphonate, a chelator that is
known to reduce the amount ofmercury in
the body. According to Morgan, it's too
early to comment on the results from these
studies.
Connections to Disease
The group examines toxicants other than
mercury, as well. For example, recent stud-
ies have focused on styrene, ox-methyl-
styrene, and divinylbenzene, chemicals that
are used in the plastics industry. After
exposing mice to these compounds, the
investigators found that styrene and divinyl-
benzene caused toxicity in the nasal cavity
and liver, but x-methylstyrene did not
prove toxic at the concentrations tested.
Moorman is using data from these stud-
ies to develop a physiologically based
pharmacokinetic model-specifically, a
computer simulation of the concentrations
of the inhaled compound and its metabo-
lites in an animal. The metabolism ofthese
three compounds includes a step in which
reactive metabolites formed in the liver are
detoxified by conjugation with glutathione.
To model this metabolism, a simulation
must calculate how much glutathione is in
the liver, which is not an easy task.
Glutathione concentrations change with
the time of day, the rate of synthesis, and
the rate of efflux from the liver, and
through loss to reactive metabolites. Says
Moorman, "When you try to model this in
a computer to run a simulation, you need
some way of calculating at each moment
how much glutathione is there so that you
can calculate the rate ofreaction. Since that
depends on several different variables, it
presents a more difficult problem." Using
data from experiments run by the group
plus data from more than 100 reference
sources, Moorman hopes to create a realis-
tic model of the metabolism of these com-
pounds. Once he is able to create a model
that produces credible data, Moorman says,
other people who are interested in risk
assessment will then be able to use the same
model to assess exposure in animals. For
example, he says, "The treated animals may
have exhibited some evidence of toxicity
such as tissue lesions, biochemical changes,
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Direct impact. Work with rats to suppress the
growth of lung fibroblasts, which lead to tis-
sue scarring, has resulted in a potential strate-
gy for treating fibrotic lung disease in humans.
or behavioral changes. Models can be used
to identify what correlates with the devel-
opment oftoxic end points. The people in
risk assessment can use information from
these models to develop similar models to
simulate what might happen in people,
which ofcourse is the whole point ofthis."
Members ofthe Respiratory Toxicology
Group often collaborate with other investi-
gators. Morgan has been working with
NIEHS pulmonary biologist James Bonner
for the past few years on vanadium pent-
oxide, a metal used in the petrochemical
industry. According to Bonner, this metal is
a source of occupational asthma in the
petrochemical industry, and trace amounts
of vanadium pentoxide are thought to be
important to the toxicity of air pollution
particulate matter. When Morgan and
Bonner exposed rats to vanadium pent-
oxide, it caused fibrosis (the buildup ofscar
tissue) in the lungs and many other features
ofasthma. Says Bonner, "Perhaps the most
significant finding so far is that we defined
the importance of two receptors-the
platelet-derived growth factor receptor and
the epidermal growth factor receptor-to
the progression oflung fibrosis and showed
that blocking these receptors with specific
tyrosine kinase inhibitors reduced the
fibrotic effect of vanadium pentoxide in
rats." He adds, "In general this offers a
potential strategy for treating patients with
fibrotic lung disease by suppressing the
growth of lung fibroblasts, the major cell
type that contributes to collagen deposition
ortissuescarring."
In many ifnot most instances, toxicolo-
gists do not yet know which inhaled com-
pounds can cause health problems or, for
those that do, how they work. And effective
treatments are currently lacking for many
inhaled toxicants. As a result, there's an
urgency to the work of the Respiratory
Toxicology Group as it seeks to understand
the air we breathe in the hopes ofmaking it
safer. -Mike May
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